Site Navigation

WCB Home Page
Change Font Size
Glossary of WCB Terms
New York State
Workers' Compensation Board
OFFICE OF THE CHAIR
328 State Street  Schenectady, New York 12305
Governor Andrew M. Cuomo


Subject No. 046-703

Temporary Suspension of Dr. Jeffrey Gundel's
Authorization to Treat Injured Workers
Effective June 16, 2014

Authorization No. 201621-5W

Date: June 30, 2014

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Jeffrey Gundel’s authorization to treat injured workers within the New York State workers’ compensation system effective June 16, 2014. Dr. Gundel's last known business address is 2 Mountain Ledge Drive, Suite 3, Wilton, New York.

The Chair’s designee’s investigation revealed that the Department of Health, Bureau of Professional Medical Conduct (BPMC) has issued BPMC Order # 14-135, wherein, Dr. Gundel entered into an Interim Order precluding him from practicing medicine in New York State or in any setting or jurisdiction where that practice is predicated on his New York State medical license. This Order was issued and became effective after his arrest on or about May 7, 2014, wherein he was charged with unlawful distribution of oxycodone.

Therefore, the Chair believes that Dr. Gundel may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Gundel is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Gundel for services rendered prior to June 16, 2014, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Gundel for services rendered prior to June 16, 2014 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

 

Robert E. Beloten
Chair